echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Approved to join, follow the "seven unifications", the new method of Guangdong pharmaceutical retail chain is here!

    Approved to join, follow the "seven unifications", the new method of Guangdong pharmaceutical retail chain is here!

    • Last Update: 2022-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On May 1, the "Guangdong Provincial Drug Retail Chain Management Supervision and Administration Measures" (referred to as the "Measures") issued by the Guangdong Provincial Drug Administration will be officially implemented
    .
    On April 20, Yan Zhen, member of the party group and deputy director of the Guangdong Provincial Drug Administration, introduced the background, main content, highlight measures and expected effects of the "Measures" at a press conference
    .
    Retail chains need to follow the "seven unifications" management regulations.
    According to Yan Zhen, the State Council attaches great importance to the reform of "delegating power, regulating services" and optimizing the business environment, requiring all relevant departments to break the shackles of systems and mechanisms, create a fair competition environment, and stimulate the vitality of market players , to realize the strategic transformation, model reconstruction and service improvement of the retail industry; the newly revised "Drug Administration Law" has made new regulations on drug retail, and the state encourages and guides drug retail chain operations; corporate headquarters engaged in drug retail chain operations, A unified quality management system shall be established to perform management responsibilities for the business activities of the subordinate retail enterprises
    .
    The revision of the new "Drug Administration Law" provides a legal basis for the chain operation supervision system; the current "Guangdong Provincial Food and Drug Administration Administration Measures for Drug Retail Chain Enterprises" in Guangdong Province is difficult to meet the needs of drug supervision and industrial development
    .
    In August 2021, the Guangdong Provincial Drug Administration launched the revision of the "Guangdong Provincial Measures for the Supervision and Administration of Drug Retail Chain Operations", which is now officially released
    .
    Drug retail chain refers to the establishment of a unified quality management system managed by the same headquarters, that is, the implementation of unified corporate identification, unified management system, unified computer system, unified personnel training, unified procurement and distribution, unified bill management, and unified pharmaceutical service standards (referred to as "" Seven unification"), to achieve large-scale, standardized and information-based management of pharmaceutical business
    .
    Yan Zhen said that the revision of the "Measures" adheres to four principles: First, adhere to the principle of keeping the bottom line of drug business quality and safety
    .
    Strengthening drug safety supervision and maintaining the safety of people's medication is the basic bottom line for revising the "Measures"
    .
    The "Measures" clarify the responsibilities of chain headquarters for the whole process management of drug purchase, storage, distribution, and sales, increase supervision over the implementation of management responsibilities by chain headquarters, and improve the quality and safety of drug business operations.

    .
    The second is to adhere to the principle of encouraging and guiding the high-quality development of chain operations
    .
    The "Measures" encourage the large-scale operation of drug retail, reduce market operating costs, and provide high-quality pharmaceutical services, which are conducive to promoting the rapid development of chain enterprises
    .
    At the same time, it is stipulated that the chain headquarters must be responsible for the distribution of drug channels and safety, and comply with the "seven unification" regulations, etc.
    , to prevent the savage growth and disorderly competition of drug retail enterprises, and guide the sustainable, healthy and high-quality development of the drug retail industry
    .
    The third is to adhere to the principle of inclusive and prudential supervision
    .
    The integration of prudential tolerance and strengthened supervision runs through the revision of the Measures
    .
    The "Measures" not only take into account the tolerance of new changes in market development, but also consider the guarantee of the safety of drug business
    .
    Drugs can be transferred between directly-operated stores of the same chain enterprise, except for refrigerated and refrigerated drugs, drugs under special management, and drugs for which the state has special management requirements
    .
    The "Measures" have made a relatively full balance and integration in two aspects
    .
    The fourth is to adhere to the principle of promoting enterprise integrity management
    .
    The revision of the "Measures" particularly emphasizes the law-abiding integrity of enterprises
    .
    The "Measures" provide a number of support policies for the development of chain enterprises, and solve difficulties and blocking problems for the development of enterprises
    .
    The "Measures" also emphasize that only honest and law-abiding enterprises can enjoy preferential policies in terms of licensing and other aspects
    .
    Conducive to improving the drug retail chain rate and standardizing the management level of retail pharmacies Yan Zhen pointed out that the "Measures" emphasized the clarification of the behavior and method of chain operation
    .
    Among them, the core and innovation of the revision of the "Measures" is to recognize the franchise behavior and make it clear that the franchise stores that follow the "seven unified" management regulations will be included in the management of retail chain stores
    .
    The promulgation of the "Measures" will effectively enhance the high-quality development level of the pharmaceutical chain industry, the level of drug safety assurance, and the ability to supervise drug safety
    .
    Specifically, it is mainly reflected in the six "favorable"
    .
    The first is to support individual pharmacies to join chain enterprises, broaden the distribution channels of chain enterprises, and increase the market share of chain enterprises in drug sales.
    Franchise pharmacies can use multiple empowerments of chain enterprises, and chain enterprises and franchise pharmacies can complement each other's advantages and share resources.
    , which is conducive to improving the level of drug retail chain rate and the standard management level of retail pharmacies, and accelerating the promotion of the large-scale, intensive and standardized development of the drug retail chain industry
    .
    The second is to allow the chain headquarters to centrally store, package and ship the drugs sold by its direct chain stores, and to transfer drugs between the direct stores, which will help reduce the cost of drug circulation for chain enterprises, promote the accelerated development of drug online sales, and facilitate consumers to purchase drugs.
    medicine
    .
    The third is to provide policy convenience for honest and law-abiding enterprises and optimize the administrative approval procedures, which is conducive to the merger and reorganization of chain enterprises, increasing the concentration, and making them bigger and stronger
    .
    The fourth is to increase the number of drug distribution companies entrusted by chain enterprises to eliminate regional barriers to drug distribution by chain enterprises, which will help chain enterprises to break through the geographical constraints of development and better meet the needs of consumers for drug purchases
    .
    The fifth is to simplify the licensing procedures for chain enterprises and chain stores, greatly improving the efficiency of administrative approval, which is conducive to optimizing the business environment and boosting the rapid development of enterprises
    .
    Sixth, improve the license data management of the drug supervision system, reduce the number of companies to submit materials and submit data, which is conducive to improving the efficiency of retail chain integration supervision and improving the level of drug safety
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.